RAI-Refractory Thyroid Cancer: Optimizing Treatment With Multikinase Inhibitors
Case 1 Early 1993
Case 1 September 1993-January 2000
DTC Surveillance Strategies
Case 1 June-August 2000
RAI-Refractory DTC Definition
RAI-Refractory DTC Use of EBRT
Case 1 March 2002-December 2009
RAI-Refractory DTC Management Options and Considerations
RAI-Refractory DTC Sorafenib and Temsirolimus
Sorafenib Common AEs
RAI-Refractory DTC Second-Line Therapy
Sorafenib and Lenvatinib Phase 3 Pivotal Trials
DECISION Trial Outcomes
SELECT Trial Outcomes
Case 2 2007-2008
Case 2 2009-2010
Case 2 2011
Thyroid Cancer MAPK Pathway and Iodine Transport
Reversing RAI Refractoriness Selumetinib Trial
Case 2 May 2013-January 2014
Case 2 January 2014-March 2015
Abbreviations
Abbreviations (cont)
Abbreviations (cont)
References
References (cont)
References (cont)
References (cont)
References (cont)